Antibiotics for Delirium
(A-DONUT Trial)
Trial Summary
What is the purpose of this trial?
Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants should have had less than 24 hours of antibiotics before the trial assessment.
Is it safe to use antibiotics for delirium?
How do antibiotics differ from other drugs for treating delirium?
Antibiotics are unique in treating delirium because they are not typically used for this condition, and some antibiotics like levofloxacin have been associated with causing delirium as a side effect. This makes their use in treating delirium novel, as they are usually known for treating infections rather than neuropsychiatric conditions.56789
Research Team
Michael Fralick, MD, PhD
Principal Investigator
Sinai Health System
Chris Kandel, MD, PhD
Principal Investigator
Michael Garron Hospital
Nathan Stall, MD, PhD
Principal Investigator
Sinai Health System
Eligibility Criteria
This trial is for adults aged 60 or older who are hospitalized with active delirium but do not have clear symptoms of a urinary tract infection. They must have had less than 24 hours of antibiotics before the trial and show signs of bacteria or white blood cells in their urine. Those with fever, UTI symptoms, long-term catheters, or other reasons for antibiotic use can't join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to receive either antibiotics or no antibiotics to assess the impact on delirium
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment for C. difficile infection
Treatment Details
Interventions
- Antibiotics (Anti-infective)
Antibiotics is already approved in Canada for the following indications:
- Appendicitis
- Intra-abdominal infections
- Surgical site infections
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mount Sinai Hospital, Canada
Lead Sponsor
Northwestern Memorial Hospital
Collaborator
Sault Area Hospital
Collaborator
Michael Garron Hospital
Collaborator
Unity Health Toronto
Collaborator
The Ottawa Hospital
Collaborator